MARCO ISLAND, Fla.--(BUSINESS WIRE)--AGBT--Agilent Technologies Inc. (NYSE:A) today announced that its Agilent SureSelect Target Enrichment System supports multiplexed DNA sequencing of 12 to 16 samples per lane depending on the next-generation sequencing platform, reducing costs and increasing throughput up to 16-fold.